NATUPHARMA A/S — Credit Rating and Financial Key Figures

NATUPHARMA A/S (CVR number: 29805601) is a company from SORØ. The company recorded a gross profit of 14 mDKK in 2025. The operating profit was 3018.6 kDKK, while net earnings were 2485.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 8 %, which can be considered decent but Return on Equity (ROE) was 12 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 43.3 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. NATUPHARMA A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.